Financial Engines Advisors L.L.C. Novartis Ag Transaction History

Financial Engines Advisors L.L.C.

  • $48.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $230,915 - $255,052
-2,709 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$83.5 - $98.47 $48,847 - $57,604
585 Added 27.54%
2,709 $232,000
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $165,820 - $200,569
2,124 New
2,124 $201,000

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Financial Engines Advisors L.L.C. Portfolio

Follow Financial Engines Advisors L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email